findmyKOL
Clinical trialNCT03266653RecruitingPhase 2Interventional

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

SponsorNew York Medical CollegeEnrollment20Epstein-Barr Virus InfectionsPrimary Immune Deficiency Disorder
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Children'S Hosptial Los Angeles

    Los Angeles, California, United States

    Recruiting
  • University of California San Francisco

    San Francisco, California, United States

    Recruiting
  • Johns Hopkins

    Baltimore, Maryland, United States

    Recruiting
  • Washington University

    St Louis, Missouri, United States

    Recruiting
  • New York Medical College

    Valhalla, New York, United States

    Mitchell S. Cairo, MD
    Recruiting
  • Nationwide Children'S Hosptial

    Columbus, Ohio, United States

    Recruiting
  • Children'S Hospital of Pennsylvania

    Philadelphia, Pennsylvania, United States

    Recruiting
  • Medical College of Wisconsin/children'S Hospital of Wisconsin

    Milwaukee, Wisconsin, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 Jul 2020
Primary completion
31 Dec 2026
Completion
31 Dec 2027
Last update posted
8 Aug 2025
Registered enrollment
20
Registry id
NCT03266653

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.